In	0	2	O
a	3	4	O
sporadic	5	13	O
Italian	14	21	O
patient	22	29	O
with	30	34	O
tetralogy	35	44	O
of	45	47	O
Fallot	48	54	O
(	55	56	O
187500	56	62	O
)	62	63	O
,	63	64	O
De	65	67	O
Luca	68	72	O
et	73	75	O
al	76	78	O
.	78	79	O

(	80	81	O
2011	81	85	O
)	85	86	O
identified	87	97	O
a	98	99	O
heterozygous	100	112	O
1632G-A	113	120	O
transition	121	131	B-Variation
in	132	134	O
exon	135	139	O
8	140	141	O
of	142	144	O
the	145	148	B-Gene
ZFPM2	149	154	I-Gene
gene	155	159	I-Gene
,	159	160	O
resulting	161	170	B-Regulation
in	171	173	I-Regulation
a	174	175	O
met544-to-ile	176	189	O
(	190	191	O
M544I	191	196	O
)	196	197	O
substitution	198	210	B-Variation
at	211	213	O
an	214	216	O
evolutionarily	217	231	O
conserved	232	241	O
residue	242	249	O
.	249	250	O

Parental	251	259	O
DNA	260	263	O
was	264	267	O
unavailable	268	279	O
for	280	283	O
analysis	284	292	O
;	292	293	O
the	294	297	O
mutation	298	306	B-Variation
was	307	310	O
not	311	314	O
found	315	320	O
in	321	323	O
500	324	327	O
population-matched	328	346	O
controls	347	355	O
.	355	356	O

In	359	361	O
a	362	363	O
Moroccan	364	372	O
patient	373	380	O
with	381	385	O
46	386	388	O
,	388	389	O
XY	389	391	O
sex	392	395	O
reversal-9	396	406	O
(	407	408	O
SRXY9	408	413	O
;	413	414	O
616067	415	421	O
)	421	422	O
,	422	423	O
Bashamboo	424	433	O
et	434	436	O
al	437	439	O
.	439	440	O

(	441	442	O
2014	442	446	O
)	446	447	O
identified	448	458	O
heterozygosity	459	473	O
for	474	477	O
a	478	479	O
de	480	482	O
novo	483	487	O
substitution	488	500	B-Variation
in	501	503	O
the	504	507	B-Gene
ZFPM2	508	513	I-Gene
gene	514	518	I-Gene
(	519	520	O
R260Q	520	525	O
;	525	526	O
603693.0010	527	538	O
)	538	539	O
as	540	542	O
well	543	547	O
as	548	550	O
homozygosity	551	563	O
for	564	567	O
the	568	571	O
M544I	572	577	O
substitution	578	590	B-Variation
.	590	591	O

The	592	595	O
proband	596	603	O
's	603	605	O
unaffected	606	616	O
second-cousin	617	630	O
parents	631	638	O
were	639	643	O
each	644	648	O
heterozygous	649	661	O
for	662	665	O
the	666	669	O
M544I	670	675	O
mutation	676	684	B-Variation
but	685	688	O
did	689	692	O
not	693	696	O
carry	697	702	O
the	703	706	O
R260Q	707	712	O
variant	713	720	B-Variation
;	720	721	O
neither	722	729	O
mutation	730	738	B-Variation
was	739	742	O
found	743	748	O
in	749	751	O
400	752	755	O
normospermic	756	768	O
ancestry-matched	769	785	O
controls	786	794	O
.	794	795	O

Bashamboo	796	805	O
et	806	808	O
al	809	811	O
.	811	812	O

(	813	814	O
2014	814	818	O
)	818	819	O
noted	820	825	O
that	826	830	O
there	831	836	O
was	837	840	O
no	841	843	O
reported	844	852	O
history	853	860	O
of	861	863	O
cardiac	864	871	O
anomalies	872	881	O
in	882	884	O
the	885	888	O
Moroccan	889	897	O
family	898	904	O
,	904	905	O
and	906	909	O
that	910	914	O
the	915	918	O
Italian	919	926	O
patient	927	934	O
reported	935	943	O
by	944	946	O
De	947	949	O
Luca	950	954	O
et	955	957	O
al	958	960	O
.	960	961	O

(	962	963	O
2011	963	967	O
)	967	968	O
had	969	972	O
no	973	975	O
reported	976	984	O
gonadal	985	992	O
anomalies	993	1002	O
.	1002	1003	O

In	1004	1006	O
functional	1007	1017	O
assays	1018	1024	O
in	1025	1027	O
HEK293T	1028	1035	O
cells	1036	1041	O
,	1041	1042	O
the	1043	1046	O
M544I	1047	1052	O
mutant	1053	1059	B-Variation
demonstrated	1060	1072	O
transactivation	1073	1088	B-Molecular_Physiological_Activity
activity	1089	1097	I-Molecular_Physiological_Activity
on	1098	1100	O
the	1101	1104	O
AMH	1105	1108	O
(	1109	1110	O
600957	1110	1116	O
)	1116	1117	O
promoter	1118	1126	O
that	1127	1131	O
was	1132	1135	O
similar	1136	1143	O
to	1144	1146	O
wildtype	1147	1155	O
,	1155	1156	O
although	1157	1165	O
there	1166	1171	O
was	1172	1175	O
a	1176	1177	O
significant	1178	1189	O
reduction	1190	1199	B-Negative_Regulation
in	1200	1202	O
the	1203	1206	O
ability	1207	1214	O
to	1215	1217	O
repress	1218	1225	B-Negative_Regulation
GATA4/NR5A1	1226	1237	O
(	1238	1239	O
184757	1239	1245	O
)	1245	1246	O
-dependent	1246	1256	O
transactivation	1257	1272	B-Molecular_Physiological_Activity
of	1273	1275	O
AMH	1276	1279	O
with	1280	1284	O
M544I	1285	1290	O
compared	1291	1299	O
to	1300	1302	O
wildtype	1303	1311	O
.	1311	1312	O

In	1313	1315	O
addition	1316	1324	O
,	1324	1325	O
the	1326	1329	O
M544I	1330	1335	O
mutant	1336	1342	B-Variation
exhibited	1343	1352	O
significantly	1353	1366	O
increased	1367	1376	B-Positive_Regulation
activation	1377	1387	B-Molecular_Physiological_Activity
of	1388	1390	O
the	1391	1394	O
SOX9	1395	1399	O
(	1400	1401	O
608160	1401	1407	O
)	1407	1408	O
enhancer	1409	1417	O
TESCO	1418	1423	O
compared	1424	1432	O
to	1433	1435	O
wildtype	1436	1444	O
.	1444	1445	O

